Research Library

The core strategies of the U.S. War on Drugs are eradication, interdiction and incarceration. After a 40-year and trillion-dollar effort, illicit drugs remain available to meet a remarkably stable demand. Drawing on decades of government-gathered and publicly available data, William Martin, director of the Drug Policy Program, and contributing expert Jerry Epstein contend that U.S. drug policy is premised on incorrect assumptions, aims at the wrong targets and can never succeed. But because these data run counter to a century of anti-drug propaganda, they play only a small role in public policy, mass-media presentation and popular perception. In this policy report, Martin and Epstein call for a reexamination of the data and sweeping revision of existing strategies. They urge formation of a politically independent national scientific commission, its members chosen by the National Academy of Sciences, in consultation with the NIH and the Department of Health and Human Services, to facilitate open examination and honest consideration of alternatives to current failed or flawed policies.

This report suggests the contours of a more comprehensive policy for the United States in the broader Middle East, one that pursues not only important tactical approaches to counter Islamic extremism and terrorism, but also shapes the larger strategic landscape to secure and promote U.S. interests. After defining the challenge for the United States and the international community, the report provides a brief narrative on the rise of ISIS before presenting key policy recommendations for a more strategic approach.

Stem cells from umbilical cord blood (CB) can be used to treat over 80 different diseases, including many types of leukemia, lymphoma and inherited immune system disorders. Extensive storage facilities in the United States and around the world collect, test and freeze CB for later use in medical procedures. However, the divide between two different banking models — public versus private — presents policy challenges. This policy report examines the difference between public and private cord blood banks and offers recommendations for US policymakers to improve cord blood banking and ensure high quality standards.

The changing regional geopolitics of the Middle East have created new opportunities for the Gulf states to engage in Arab-Israeli conflict resolution after the Arab Spring. This policy report examines the potential role that the six Gulf Cooperation Council (GCC) states — Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and the United Arab Emirates (UAE) — might play in Israeli-Palestinian conflict resolution. It presents policy recommendations on how the Gulf states can engage with regional and international partners and build upon the greater space for action as the shifting parameters of Middle East politics create new regional pathways for action and cooperation.

In March 2009, the James A. Baker III Institute for Public Policy and the Qatar Foundation for Education, Science and Community Development co-hosted a workshop in Doha, Qatar, on stem cell research, policies, and regulations. The event highlighted current stem cell science, as well as stem cell policies and ethics. The discussion focused on policies around the globe and the religious views of embryonic stem cell research from the Christian, Jewish, and Muslim perspectives. The workshop was organized so that outcomes from the event could be relevant to the development of Qatar"s up-and-coming stem cell research. Based on the presentation from the event, the advisory panel for the Baker Institute International Stem Cell Policy Program made a series of recommendations for the new stem cell initiative in Qatar, including the suggestion for outreach to the Qatari community.